Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age
NCT05500326Phase 2Active, not recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CHILD-IVITAB in scabies, sponsored by Murdoch Children's Research Institute. Started Jun 2025; status: active, not recruiting.
02
Drugs
CHILD-IVITAB
03
Conditions
scabies
Beyond the preview
Go deeper on NCT05500326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05500326.